After receiving high praise from users for the NEPA21 efficient gene transfection system and ECFC21 electrofusion instrument, NEPA GENE has launched a new generation of versatile ELEPO21 in vitro high-efficiency electrofusion instrument. ELEPO21 adopts a new dead end program, which not only inherits the high transfection efficiency and high survival rate advantages of NEPA21 in the field of animal cell transfection, but also introduces a high-voltage electrical conversion mode, which can be used in one machine and improves the conversion efficiency of bacteria, fungi, and yeast. It still has the advantages of simple operation, visible and adjustable electric conversion parameters, and strong applicability.